Abo Akademi University, Finland
👨‍🎓Professional ProfileÂ
Orcid Profile
👩‍🔬 Summary
Ms. Farnaz Shokraneh is an experienced pharmaceutical professional currently working as a Doctoral Researcher in Pharmaceutical Development and Medical Technology at Ă…bo Akademi University in Turku, Finland. With a solid academic background and extensive practical experience in pharmaceutical quality assurance, regulatory compliance, and research, she brings valuable insights into the development of pharmaceutical products and systems. She is committed to advancing personalized medicine and improving quality control in the pharmaceutical industry.
🎓 Education
Ms. Shokraneh holds a Doctor of Pharmacy degree, equivalent to a Finnish Master’s, from Islamic Azad University, Tehran, Iran (2007-2012). She furthered her academic journey with a Master’s in Pharmaceutical Research from Freie Universität Berlin, Germany (2022-2024). Currently, she is pursuing her doctoral research in Pharmaceutical Development and Medical Technology at Åbo Akademi University, Turku, Finland (2022–present).
đź’Ľ Professional Experience
Ms. Shokraneh has accumulated extensive experience in various roles within the pharmaceutical industry. She is currently serving as a Quality Manager at CurifyLabs Oy in Helsinki, Finland, since September 2022. Previously, she held the position of Quality Assurance Manager at Mofid Pharma under the license of Bayer Pharmaceutical Company (Dec 2020–Dec 2021). Additionally, she has worked at Modava Pharmaceutical under Novartis (Jul 2018–Jul 2020) and ATI Pharmed Pharmaceutical Co under StragenPharma and CHEMO Pharmaceutical licenses (Apr 2013–Jun 2017).
🛠️ Technical Skills
Ms. Shokraneh’s technical expertise encompasses pharmaceutical development, quality assurance, and regulatory compliance. She is proficient in analytical techniques such as HPLC, mass spectrometry, and micro NIR spectrophotometry. Her experience also extends to pharmacovigilance, safety monitoring, and statistical analysis for pharmaceutical applications, making her highly skilled in ensuring the safety, efficacy, and quality of pharmaceutical products.
🧑‍🏫 Teaching Experience
Although Ms. Shokraneh’s current focus is on research and industry roles, her vast knowledge and experience in the pharmaceutical field allow her to effectively mentor teams and share her expertise. She has contributed to the professional development of her colleagues and participated in educational training programs within the pharmaceutical sector.
🔬 Research Interests
Ms. Shokraneh’s primary research interests lie in pharmaceutical development and medical technology, with a particular focus on personalized medicine. She is passionate about improving drug safety and efficacy through innovations in automated pharmacy compounding, quality control, and exploring new methods for drug delivery and patient-specific treatment plans.
đź“–Top Noted Publications
Automated Non-Sterile Pharmacy Compounding: A Multi-Site Study in European Hospital and Community Pharmacies with Pediatric Immediate Release Propranolol Hydrochloride Tablets
Authors: Niklas Sandler Topelius, Farnaz Shokraneh, Mahsa Bahman, Julius Lahtinen, Niko Hassinen, Sari Airaksinen, Soumya Verma, Ludmila Hrizanovska, Jana Lass, Urve Paaver et al.
Journal: Pharmaceutics
Year: 2024
A Novel High Performance Liquid Chromatographic Method for Determination of Nystatin in Pharmaceutical Formulations by Box–Behnken Statistical Experiment Design
Authors: Farnaz Shokraneh
Journal: Iranian Journal of Pharmaceutical Research
Year: 2014
Comparative Studies of Cytotoxic Manufacturing Practices in Specialized Cancer Centers Against International Guidelines (ASHP, OSHA, HSE-UK)
Authors: Farnaz Shokraneh
Journal: FIP Congress
Year: 2012
Development and Validation of High-Performance Liquid Chromatography for Determination of Nystatin in Pharmaceutical Formulations
Authors: Farnaz Shokraneh
Journal: Research in Pharmaceutical Science
Year: 2012
A New HPLC Method for Determination of Losartan in Human Plasma and Its Application in Bioequivalence Studies
Authors: Farnaz Shokraneh
Journal: Oriental Journal of Chemistry
Year: 2012
Risks to Health Professionals from Hazardous Drugs in Iran: A Pilot Study of Understanding of Healthcare Team to Occupational Exposure to Cytotoxics
Authors: Farnaz Shokraneh
Journal: EXCLI Journal
Year: 2005